Advertisement

Antiviral Treatment of Bell's Palsy Based on Baseline Severity: A Systematic Review and Meta-analysis

Published:December 29, 2014DOI:https://doi.org/10.1016/j.amjmed.2014.11.033

      Abstract

      Purpose

      We conducted a systematic review with meta-analysis to evaluate the efficacy of antiviral agents on complete recovery of Bell's palsy.

      Methods

      We searched CENTRAL, Embase, MEDLINE, International Pharmaceutical Abstracts, and sources of unpublished literature to November 1, 2014. Primary and secondary outcomes were complete and satisfactory recovery, respectively. To evaluate statistical heterogeneity, we performed subgroup analysis of baseline severity of Bell's palsy and between-study sensitivity analyses based on risk of allocation and detection bias.

      Results

      The 10 included randomized controlled trials (2419 patients; 807 with severe Bell's palsy at onset) had variable risk of bias, with 9 trials having a high risk of bias in at least 1 domain. Complete recovery was not statistically significantly greater with antiviral use versus no antiviral use in the random-effects meta-analysis of 6 trials (relative risk, 1.06; 95% confidence interval, 0.97-1.16; I2 = 65%). Conversely, random-effects meta-analysis of 9 trials showed a statistically significant difference in satisfactory recovery (relative risk, 1.10; 95% confidence interval, 1.02-1.18; I2 = 63%). Response to antiviral agents did not differ visually or statistically between patients with severe symptoms at baseline and those with milder disease (test for interaction, P = .11). Sensitivity analyses did not show a clear effect of bias on outcomes.

      Conclusions

      Antiviral agents are not efficacious in increasing the proportion of patients with Bell's palsy who achieved complete recovery, regardless of baseline symptom severity.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • De Diego-Sastre J.I.
        • Prim-Espada M.P.
        • Fernandez-Garcia F.
        The epidemiology of Bell's palsy [Spanish].
        Rev Neurol. 2005; 41: 287-290
        • Adour K.K.
        • Bell D.N.
        • Hilsinger R.L.
        Herpes simplex virus in idiopathic facial paralysis (Bell palsy).
        JAMA. 1975; 233: 527-530
        • Murakami S.
        • Mizobuchi M.
        • Nakashiro Y.
        • Doi T.
        • Hato N.
        • Yanagihara N.
        Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle.
        Ann Intern Med. 1996; 124: 27-30
        • Furuta Y.
        • Fukuda S.
        • Suzuki S.
        • Takasu T.
        • Inuyama Y.
        • Nagashima K.
        Detection of varicella-zoster DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete.
        J Med Virol. 1997; 52: 316-319
        • Salinas R.A.
        • Alvarez G.
        • Daly F.
        • Ferreira J.
        Corticosteroids for Bell's palsy (idiopathic facial paralysis).
        Cochrane Database Syst Rev. 2010; 3: CD001942
        • Quant E.C.
        • Jeste S.S.
        • Muni R.H.
        • Cape A.V.
        • Bhussar M.K.
        • Peleg A.Y.
        The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis.
        BMJ. 2009; 339: b3354
        • Goudakos J.K.
        • Markou K.D.
        Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy.
        Arch Otolaryngol Head Neck Surg. 2009; 135: 558-564
        • Lockhart P.
        • Daly F.
        • Pitkethly M.
        • Comerford N.
        • Sullivan F.
        Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
        Cochrane Database Syst Rev. 2009; 4: CD001869
        • De Almeida J.R.
        • Al Khabori M.
        • Guyatt G.H.
        • et al.
        Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis.
        JAMA. 2009; : 985-993
        • Gronseth G.S.
        • Paduga R.
        Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology.
        Neurology. 2012; 79: 2209-2213
        • Mantsopoulos K.
        • Psillas G.
        • Psychogios G.
        • Brase C.
        • Iro H.
        • Constantinidis J.
        Predicting the long-term outcome after idiopathic facial nerve paralysis.
        Otol Neurotol. 2011; 32: 848-851
        • Sullivan F.
        • Swan I.
        • Daly F.
        Prednisolone or acyclovir in Bell's palsy [author's reply].
        N Engl J Med. 2008; 358: 307
        • Hato N.
        • Murakami S.
        • Gyo K.
        Steroid and antiviral treatment for Bell's palsy.
        Lancet. 2008; 371: 1818-1820
        • Hato N.
        • Sawai N.
        • Teraoka M.
        • et al.
        Valacyclovir for the treatment of Bell's palsy.
        Expert Opin Pharmacother. 2008; 9: 2531-2536
        • Higgins J.P.T.
        • Altman D.G.
        • Sterne J.A.C.
        Chapter 8: Assessing risk of bias in included studies.
        in: Higgins J.P.T. Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. (updated March 2011). The Cochrane Collaboration, Oxford, England2011
        • Berg T.
        • Jonsson L.
        • Engstrom M.
        Agreement between the Sunnybrook, House-Brackmann, and Yanagihara facial nerve grading systems in Bell's palsy.
        Otol Neurotol. 2004; 25: 1020-1026
        • Sterne J.A.C.
        • Egger M.
        • Moher D.
        Chapter 10: Addressing reporting biases.
        (updated March 2011)in: Higgins J.P.T. Green S. Cochrane Handbook for Systematic Reviews of Intervention Version 5.1.0. The Cochrane Collaboration, Oxford, England2011
        • Adour K.K.
        • Ruboyianes J.M.
        • Von Doersten P.G.
        • et al.
        Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial.
        Ann Otol Rhinol Laryngol. 1996; 105: 371-378
        • Li Y.
        • Gao P.
        • Mao X.
        • Cao P.
        Randomized clinical trial of acyclovir plus prednisone versus prednisone alone in Bell's palsy.
        Ceylon J Med Sci. 1997; 40: 37-41
        • Kawaguchi K.
        • Inamura H.
        • Abe Y.
        • et al.
        Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy.
        Laryngoscope. 2007; 117: 147-156
        • Hato N.
        • Yamada H.
        • Kohno H.
        • et al.
        Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study.
        Otol Nerotol. 2007; 28: 408-413
        • Sullivan F.M.
        • Swan I.R.C.
        • Donnan P.T.
        • et al.
        Early treatment with prednisolone or acyclovir in Bell's palsy.
        N Engl J Med. 2007; 357: 1598-1607
        • Sullivan F.M.
        • Swan I.R.C.
        • Donnan P.T.
        • et al.
        A randomised controlled trial of the use of acyclovir and/or prednisolone for the early treatment of Bell's palsy: the BELLS study.
        Health Technol Assess. 2009; 13 (iii-iv, ix-xi 1-130)
        • Yeo S.G.
        • Lee Y.C.
        • Park D.C.
        • Cha C.I.
        Acyclovir plus steroid vs steroid alone in the treatment of Bell's palsy.
        Am J Otolaryngol. 2008; 29: 163-166
        • Minnerop M.
        • Herbst M.
        • Fimmers R.
        • et al.
        Bell's palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone.
        J Neurol. 2008; 255: 1726-1730
        • Engstrom M.
        • Berg T.
        • Stjernquist-Desatnik A.
        • et al.
        Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial.
        Lancet Neurol. 2008; 7: 993-1000
        • Axelsson S.
        • Berg T.
        • Jonsson L.
        • Engstrom M.
        • Kanerva M.
        • Stjernquist-Desatnik A.
        Bell's palsy – the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial.
        Clin Otolaryngol. 2012; 37: 283-290
        • Shahidullah M.
        • Haque A.
        • Islam M.R.
        • et al.
        Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy.
        Mymensingh Med J. 2011; 20: 605-613
        • Lee H.Y.
        • Byun J.Y.
        • Park M.S.
        • Yeo S.G.
        Steroid-antiviral treatment improves the recovery rate in patients with severe Bell's palsy.
        Am J Med. 2013; 126: 336-341
        • Oh I.W.
        • Yeo S.G.
        The reply.
        Am J Med. 2013; 126: e33
        • Savovic J.
        • Jones H.E.
        • Altman D.G.
        • et al.
        Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.
        Ann Intern Med. 2012; 157: 429-438